Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage (Q33869261)

29 July 2017

title

Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage (English)

1 reference

29 July 2017

1 reference

peginterferon alfa-2a

1 reference

1 reference

M F Derbala

1

1 reference

29 July 2017

S R Al Kaabi

2

1 reference

29 July 2017

N Z El Dweik

3

1 reference

29 July 2017

F Pasic

4

1 reference

29 July 2017

M T Butt

5

1 reference

29 July 2017

R Yakoob

6

1 reference

29 July 2017

A Al-Marri

7

1 reference

29 July 2017

A M Amer

8

1 reference

29 July 2017

N Morad

9

1 reference

29 July 2017

A Bener

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

World Journal of Gastroenterology

29 July 2017

published in

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

issue

35

1 reference

29 July 2017

page(s)

5692-5698

1 reference

Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Review article: pegylated interferons: chemical and clinical differences

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Infection with hepatitis C virus genotype 4 in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Hematologic disorders associated with hepatitis C virus infection and their management

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Clinical significance of hepatitis C virus genotypes and quasispecies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

HCV-RNA levels play an important role independently of genotype in predicting response to interferon therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

The relationship between hepatitis C virus and schistosomiasis: histopathologic evaluation of liver biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Treatment of chronic hepatitis C genotype IV with interferon-ribavirin combination in Saudi Arabia: a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I35.5692

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

Does schistosomiasis interfere with application of the Knodell score for assessment of chronic hepatitis C?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088172

29 October 2018

Identifiers

DOI

10.3748/WJG.V12.I35.5692

1 reference

29 July 2017

1 reference

29 July 2017

1 reference